Mark Murcko
Founder at RELAY THERAPEUTICS, INC.
Net worth: 6 M $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Leiden | M | 68 | 15 years | |
| Amir Nashat | M | 51 |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA.
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 7 years |
| Alexis Borisy | M | 52 | 9 years | |
| Imogen Pryce | M | - | 4 years | |
| Sri Kosuri | M | - |
Octant, Inc.
 Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | 11 years |
| Praveen Tipirneni | M | 55 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 9 years |
| Steven Schmidt | M | - |
Quvium UK Ltd.
 Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | 11 years |
| Ramsey Homsany | M | - |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | 11 years |
| Travis Murdoch | M | - |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | 3 years |
| Sanjiv Patel | M | 50 | 7 years | |
| Timothy Springer | M | 76 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 10 years |
| Peter Rahmer | M | - | 4 years | |
| Krzysztof Matyjaszewski | M | - |
Biohybrid Solutions Holding, Inc.
 Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | - |
| Alan Russell | M | - |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | 8 years |
| Brian Adams | M | 50 | 6 years | |
| William DeVaul | M | 53 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Ameet Nathwani | M | 60 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 4 years |
| Amit Sachdev | M | 56 | 17 years | |
| Nancy Gray | M | 64 |
Gordon Research Conferences
| 21 years |
| Marc Schegerin | M | 48 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 4 years |
| Sekar Kathiresan | M | 52 | 2 years | |
| Karen Travers | F | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | 11 years |
| Antonina Simakova | M | - |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | 8 years |
| Anthony A. Hyman | M | - |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 6 years |
| Barbara Krebs-Pohl | M | - |
HIBio, Inc.
 HIBio, Inc. BiotechnologyHealth Technology HIBio, Inc. is a clinical immunology company that leverages human genetic and immunological insights to deliver targeted therapies to patients with severe immune-mediated diseases. The company is based in South San Francisco, CA. HIBio is excited to work as part of a collaborative team. HIBio was founded by Tim Behrens and Travis Murdoch, with Travis Murdoch serving as the CEO since incorporation.
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | - |
| Jean Pineault | M | - |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | 3 years |
| Laura Shawver | M | 66 | 7 years | |
| Linda Hill | M | 67 | 6 years | |
| Jami Rubin | F | 60 | 5 years | |
| Paul S. Anderson | M | 85 |
Gordon Research Conferences
| - |
| Richard Young | M | 70 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 4 years |
| Douglas Ingram | M | 61 | 5 years | |
| Bruce Sachs | M | 64 | 26 years | |
| Norbert W. Bischofberger | M | 68 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 years |
| Amy Schulman | F | 63 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | - |
| Christopher Hare | M | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | - |
| David Bell | M | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | 10 years |
| Robert Kittler | M | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | - |
| Philip Hunt | M | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | - |
| Gill Inman | F | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | - |
| Edward A. Dennis | M | 82 |
Gordon Research Conferences
| 16 years |
| Peng Wu | F | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | - |
| Thomas Catinazzo | M | 47 | 6 years | |
| Ben Wolf | M | - | 5 years | |
| Rachel Mears | F | - |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | - |
| Regina Barzilay | M | - |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 3 years |
| Patrick Riley | M | - | 3 years | |
| Ulrich Von Adrian | M | - |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Jeanne Gray | F | - | - | |
| Brihad Abhyankar | M | - |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 2 years |
| Srini Akkaraju Akkaraju | M | 56 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | - |
| Pat Walters | M | - | - | |
| Carol Suh | F | 33 |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | 3 years |
| Paul Berns | M | 57 |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | 3 years |
| Joseph Slattery | M | 59 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 years |
| Vikas Goyal | M | 45 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Otello Stampacchia | M | 55 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 years |
| Martin Edwards | M | 68 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| James Bristol | M | 77 |
Gordon Research Conferences
| - |
| Olivier Brandicourt | M | 68 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 4 years |
| Robert Farrell | M | 58 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 9 years |
| Frances Arnold | M | 67 |
Gordon Research Conferences
| - |
| Anthony Weiss | M | - |
Gordon Research Conferences
| - |
| Jorge Conde | M | 47 |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | - |
| Michael A. Foley | M | 62 |
Quentis Therapeutics, Inc.
 Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | - |
| John Kozarich | M | 74 |
Gordon Research Conferences
| - |
| Gustav Christensen | M | 76 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Sunil Agarwal | M | 54 |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | 1 years |
| Nilesh Kumar | M | 47 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 years |
| Donald Bergstrom | M | 52 | 6 years | |
| Fred Cohen | M | 67 |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | - |
| Susannah Gray | F | 63 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 3 years |
| Jason Kelly | M | 43 |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | - |
| Jürgen Eckhardt | M | 57 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 5 years |
| Dan Budwick | M | - | - | |
| Cheung Hoi Yu | M | 69 |
Gordon Research Conferences
| 10 years |
| Jim Watters | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Emmens | M | 72 | - | |
| TY Howton | M | 52 | 3 years | |
| Paul Silva | M | 58 | 14 years | |
| Eugene H. Cordes | M | 87 | - | |
| Sarah Bettigole | F | - |
Quentis Therapeutics, Inc.
Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | 4 years |
| Jakob Loven | M | 46 | - | |
| Christoph S. Lengauer | M | 59 | - | |
| Wayne Riley | M | 64 | 5 years | |
| Steven Kafka | M | 54 | 1 years | |
| Dipchand Nishar | M | 54 | 2 years | |
| Wei Li | M | 52 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | 6 years |
| Ian Smith | M | 58 | 18 years | |
| Keith S. Ehrlich | M | 73 | 2 years | |
| Terrence Kearney | M | 69 | 13 years | |
| Margaret McGlynn | F | 64 | 12 years | |
| Thomas Auchincloss | M | 62 | 7 years | |
| Richard H. Aldrich | M | 69 | 12 years | |
| Elaine S. Ullian | F | 76 | 22 years | |
| Dennis L. Winger | M | 77 | 3 years | |
| Stuart J. M. Collinson | M | 64 | 9 years | |
| Andy Porter | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 91.84% |
| United Kingdom | 8 | 8.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Murcko
- Personal Network
